Slow increase of homovanillic acid in cerebrospinal fluid after levodopa administration

被引:9
作者
Raftopoulos, C
Dethy, S
Laute, MA
Goldman, S
Naini, AB
Przedborski, S
Hildebrand, J
机构
[1] FREE UNIV BRUSSELS,HOP ERASME,SERV NEUROL,B-1070 BRUSSELS,BELGIUM
[2] FREE UNIV BRUSSELS,HOP ERASME,SERV NEUROCHIRURG,B-1070 BRUSSELS,BELGIUM
[3] COLUMBIA UNIV,DEPT NEUROL,MOVEMENT DISORDER GRP,NEW YORK,NY
关键词
homovanillic acid; dopamine; carbidopa; levodopa; 3,4-dihydroxyphenylacetic acid;
D O I
10.1002/mds.870110111
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Concentrations of major catabolites of dopamine were followed in the ventricular cerebrospinal fluid (CSF) in five patients undergoing intracranial pressure monitoring for chronic hydrocephalus. Determinations were made every 2 h following the administration of carbidopa/levodopa 25/250 mg (one Sinemet capsule) given 8 h apart. The rise of homovanillic acid (HVA) concentrations was slow and progressive, reaching the level of statistical significance (p less than or equal to 0.01) only 8 h after the second administration of Sinemet. The rise in 3,4-dihydroxyphenylacetic acid (DOPAC) was faster than the rise in HVA, with the peak value detected 4 h after the first administration of Sinemet. These data are interpreted as a confirmation, in humans, of a slow pool of exogenous levodopa, previously demonstrated in animal studies.
引用
收藏
页码:59 / 62
页数:4
相关论文
共 15 条
[1]  
[Anonymous], THERAPY PARKINSONS D
[2]  
DETHY S, IN PRESS J NEUROL T
[3]   EFFECT OF L-DOPA ON DEMENTIA-RELATED RIGIDITY [J].
DURET, M ;
GOLDMAN, S ;
MESSINA, D ;
HILDEBRAND, J .
ACTA NEUROLOGICA SCANDINAVICA, 1989, 80 (01) :64-67
[4]   THE TRANSPORT OF L-6-FLUORODOPA AND ITS METABOLITES FROM BLOOD TO CEREBROSPINAL-FLUID AND BRAIN [J].
HAMMERSTAD, JP ;
PATE, BD ;
HEWITT, KA ;
CHAN, GLY ;
RUTH, TJ ;
CALNE, DB .
ANNALS OF NEUROLOGY, 1993, 34 (04) :603-608
[5]   L-DOPA PHARMACOKINETICS IN PLASMA AND CISTERNAL AND LUMBAR CEREBROSPINAL-FLUID OF MONKEYS [J].
HAMMERSTAD, JP ;
WOODWARD, WR ;
GLIESSMAN, P ;
BOUCHER, B ;
NUTT, JG .
ANNALS OF NEUROLOGY, 1990, 27 (05) :495-499
[6]  
HILDEBRAND J, 1990, ACTA NEUROL SCAND, V81, P427
[7]   MARKERS OF DOPAMINE METABOLISM IN PARKINSONS-DISEASE [J].
LEWITT, PA ;
GALLOWAY, MP ;
MATSON, W ;
MILBURY, P ;
MCDERMOTT, M ;
SRIVASTAVA, DK ;
OAKES, D .
NEUROLOGY, 1992, 42 (11) :2111-2117
[8]  
LINDVALL B, 1990, ADV NEUROL, V53, P117
[9]   COMPARATIVE INVIVO METABOLISM OF 6-[F-18]FLUORO-L-DOPA AND [H-3] L-DOPA IN RATS [J].
MELEGA, WP ;
LUXEN, A ;
PERLMUTTER, MM ;
NISSENSON, CHK ;
PHELPS, ME ;
BARRIO, JR .
BIOCHEMICAL PHARMACOLOGY, 1990, 39 (12) :1853-1860
[10]   LACK OF CHANGES IN VENTRICULAR CEREBROSPINAL-FLUID CONCENTRATIONS OF HOMOVANILLIC-ACID FOLLOWING ACUTE CHALLENGE WITH LEVODOPA [J].
MOUSSA, Z ;
RAFTOPOULOS, C ;
PRZEDBORSKI, S ;
HILDEBRAND, J .
ANNALS OF NEUROLOGY, 1992, 31 (01) :113-114